
Grant Sitta
Examiner (ID: 10734, Phone: (571)270-1542 , Office: P/2622 )
| Most Active Art Unit | 2622 |
| Art Unit(s) | 2694, 2622, 2629 |
| Total Applications | 1002 |
| Issued Applications | 677 |
| Pending Applications | 79 |
| Abandoned Applications | 280 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17689391
[patent_doc_number] => 20220196684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => METHOD FOR DETECTING OR MONITORING THE DEVELOPMENT OF A CHRONIC DEGENERATIVE DISEASE BY IMMUNOASSAY
[patent_app_type] => utility
[patent_app_number] => 17/600738
[patent_app_country] => US
[patent_app_date] => 2020-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17600738
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/600738 | METHOD FOR DETECTING OR MONITORING THE DEVELOPMENT OF A CHRONIC DEGENERATIVE DISEASE BY IMMUNOASSAY | Mar 31, 2020 | Pending |
Array
(
[id] => 16178262
[patent_doc_number] => 20200225230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => COMBINATION TREPONEMAL AND NON-TREPONEMAL SYPHILIS TEST
[patent_app_type] => utility
[patent_app_number] => 16/832608
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16832608
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/832608 | Combination treponemal and non-treponemal syphilis test | Mar 26, 2020 | Issued |
Array
(
[id] => 16932728
[patent_doc_number] => 20210198617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => PARTICULATE STRUCTURE WITH A HIGH CONCENTRATION OF LIVE BACTERIA AND METHOD OF PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/826892
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16826892
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/826892 | Particulate structure with a high concentration of live bacteria and method of preparing the same | Mar 22, 2020 | Issued |
Array
(
[id] => 18034681
[patent_doc_number] => 20220378896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => VACCINE COMPOSITIONS AND METHODS FOR REDUCING TRANSMISSION OF STREPTOCOCCUS PNEUMONIAE
[patent_app_type] => utility
[patent_app_number] => 17/602414
[patent_app_country] => US
[patent_app_date] => 2020-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602414
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/602414 | VACCINE COMPOSITIONS AND METHODS FOR REDUCING TRANSMISSION OF STREPTOCOCCUS PNEUMONIAE | Mar 11, 2020 | Pending |
Array
(
[id] => 16341675
[patent_doc_number] => 20200306325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => PROBIOTIC CONSORTIA FOR ORAL HEALTH
[patent_app_type] => utility
[patent_app_number] => 16/811517
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16811517
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/811517 | PROBIOTIC CONSORTIA FOR ORAL HEALTH | Mar 5, 2020 | Abandoned |
Array
(
[id] => 17236670
[patent_doc_number] => 11180542
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Stabilized liquid anti-RSV antibody formulations
[patent_app_type] => utility
[patent_app_number] => 16/807420
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 28208
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16807420
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/807420 | Stabilized liquid anti-RSV antibody formulations | Mar 2, 2020 | Issued |
Array
(
[id] => 16343942
[patent_doc_number] => 20200308592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => CONTROLLING BACTERIAL BIOFILMS
[patent_app_type] => utility
[patent_app_number] => 16/795726
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795726
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795726 | CONTROLLING BACTERIAL BIOFILMS | Feb 19, 2020 | Abandoned |
Array
(
[id] => 16389663
[patent_doc_number] => 20200330604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => PREPARATION OF MAYTANSINOID ANTIBODY CONJUGATES BY A ONE-STEP PROCESS
[patent_app_type] => utility
[patent_app_number] => 16/787942
[patent_app_country] => US
[patent_app_date] => 2020-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17149
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16787942
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/787942 | Preparation of maytansinoid antibody conjugates by a one-step process | Feb 10, 2020 | Issued |
Array
(
[id] => 16540991
[patent_doc_number] => 20200407404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => MODIFIED BIOTIN-BINDING PROTEIN, FUSION PROTEINS THEREOF AND APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 16/785937
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16785937
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/785937 | Modified biotin-binding protein, fusion proteins thereof and applications | Feb 9, 2020 | Issued |
Array
(
[id] => 16743457
[patent_doc_number] => 10968432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Proteins increasing pancreatic b cell number and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/783864
[patent_app_country] => US
[patent_app_date] => 2020-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 28
[patent_no_of_words] => 17245
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16783864
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/783864 | Proteins increasing pancreatic b cell number and methods of use | Feb 5, 2020 | Issued |
Array
(
[id] => 17000576
[patent_doc_number] => 11079380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Optimizing diagnostics for galactofuranose containing antigens
[patent_app_type] => utility
[patent_app_number] => 16/750720
[patent_app_country] => US
[patent_app_date] => 2020-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11754
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 239
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16750720
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/750720 | Optimizing diagnostics for galactofuranose containing antigens | Jan 22, 2020 | Issued |
Array
(
[id] => 17193350
[patent_doc_number] => 11162093
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Antigen screening system
[patent_app_type] => utility
[patent_app_number] => 16/744690
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13872
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744690
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/744690 | Antigen screening system | Jan 15, 2020 | Issued |
Array
(
[id] => 18166950
[patent_doc_number] => 20230033556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => SYSTEM AND METHOD FOR DETECTING A BIOLOGICAL ANALYTE, INCLUDING A MICROORGANISM, BY A CHANGE IN THE MAGNETIC PROPERTY OF A SUBSTRATE, USING SUPERPARAMANGNETIC NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/758288
[patent_app_country] => US
[patent_app_date] => 2019-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758288
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/758288 | SYSTEM AND METHOD FOR DETECTING A BIOLOGICAL ANALYTE, INCLUDING A MICROORGANISM, BY A CHANGE IN THE MAGNETIC PROPERTY OF A SUBSTRATE, USING SUPERPARAMANGNETIC NANOPARTICLES | Dec 30, 2019 | Pending |
Array
(
[id] => 17474178
[patent_doc_number] => 20220081682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => BOTULINUM TOXIN PRODUCING METHOD
[patent_app_type] => utility
[patent_app_number] => 17/416342
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13206
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416342
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416342 | Botulinum toxin producing method | Dec 16, 2019 | Issued |
Array
(
[id] => 16153787
[patent_doc_number] => 20200215126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 16/713911
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16713911
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/713911 | Compositions comprising bacterial strains | Dec 12, 2019 | Issued |
Array
(
[id] => 16086643
[patent_doc_number] => 20200197308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => Surface display of antigens on Gram-negative outer membrane vesicles
[patent_app_type] => utility
[patent_app_number] => 16/702660
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20999
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16702660
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/702660 | Surface display of antigens on Gram-negative outer membrane vesicles | Dec 3, 2019 | Issued |
Array
(
[id] => 20109399
[patent_doc_number] => 12360111
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-15
[patent_title] => G protein-coupled receptor screening systems
[patent_app_type] => utility
[patent_app_number] => 17/296818
[patent_app_country] => US
[patent_app_date] => 2019-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 71
[patent_figures_cnt] => 138
[patent_no_of_words] => 12730
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296818
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296818 | G protein-coupled receptor screening systems | Dec 2, 2019 | Issued |
Array
(
[id] => 16420642
[patent_doc_number] => 20200345840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/701948
[patent_app_country] => US
[patent_app_date] => 2019-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16701948
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/701948 | QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF | Dec 2, 2019 | Abandoned |
Array
(
[id] => 17265877
[patent_doc_number] => 11191277
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Method of identifying a biologically-active composition from a biofilm
[patent_app_type] => utility
[patent_app_number] => 16/699383
[patent_app_country] => US
[patent_app_date] => 2019-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14794
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16699383
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/699383 | Method of identifying a biologically-active composition from a biofilm | Nov 28, 2019 | Issued |
Array
(
[id] => 15681347
[patent_doc_number] => 20200095337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => Lincosamides Universal Monoclonal Antibody Hybridoma Cell Strain and Application Thereof
[patent_app_type] => utility
[patent_app_number] => 16/699048
[patent_app_country] => US
[patent_app_date] => 2019-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2787
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16699048
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/699048 | Lincosamides universal monoclonal antibody hybridoma cell strain and application thereof | Nov 27, 2019 | Issued |